Enrique Carrazana, M.D.
Senior Vice President, Strategic Initiatives
Dr. Enrique Carrazana has over 25 years of experience in drug development and the pharmaceutical industry. Dr. Carrazana is a member of the board of directors of CND Life Sciences, Hawaii Biotech, Apex Labs, and the American Society for Experimental Neurotherapeutics. He currently serves as the Senior Vice President of Strategic Initiatives for Neurelis, Inc., where he is responsible for the scientific and clinical aspects of identifying, evaluating, negotiating, and managing strategic business opportunities that further Neurelis’ corporate strategy. Dr. Carrazana was previously the Chief Medical Officer for Neurelis, a position he also held at Acorda Therapeutics. Dr. Carrazana also held various medical leadership roles at Novartis, where his last role was Vice President, Global Head Development Established Medicines Franchise, based in Basel, Switzerland. He was Director of the Epilepsy Center of Excellence at the Miami Veterans' Administration (VA) Hospital and Associate Professor of Neurology at the University of Miami, Miller School of Medicine. He has presented and published a wide range of research on various neurology topics. Dr. Carrazana received his medical degree from Harvard Medical School and completed his residency in neurology and fellowship in neurophysiology at the Harvard Longwood Neurology Program. He is a board-certified neurologist and a Fellow of the American Epilepsy Society.
Enrique Carrazana, M.D.
Senior Vice President, Strategic Initiatives
Dr. Enrique Carrazana has over 25 years of experience in drug development and the pharmaceutical industry. Dr. Carrazana is a member of the board of directors of CND Life Sciences, Hawaii Biotech, Apex Labs, and the American Society for Experimental Neurotherapeutics. He currently serves as the Senior Vice President of Strategic Initiatives for Neurelis, Inc., where he is responsible for the scientific and clinical aspects of identifying, evaluating, negotiating, and managing strategic business opportunities that further Neurelis’ corporate strategy. Dr. Carrazana was previously the Chief Medical Officer for Neurelis, a position he also held at Acorda Therapeutics. Dr. Carrazana also held various medical leadership roles at Novartis, where his last role was Vice President, Global Head Development Established Medicines Franchise, based in Basel, Switzerland. He was Director of the Epilepsy Center of Excellence at the Miami Veterans' Administration (VA) Hospital and Associate Professor of Neurology at the University of Miami, Miller School of Medicine. He has presented and published a wide range of research on various neurology topics. Dr. Carrazana received his medical degree from Harvard Medical School and completed his residency in neurology and fellowship in neurophysiology at the Harvard Longwood Neurology Program. He is a board-certified neurologist and a Fellow of the American Epilepsy Society.